Order by stock part number »
Get Help
 |  EN
Sign In
ProcessingProcessing
Back

Laurentijn Tilleman

Pan-cancer pharmacogenetics: Targeted sequencing panels or exome sequencing?

Laurentijn Tilleman graduated from the Faculty of Bioscience Engineering at Ghent University in 2016. He is now working on his PhD at Ghent University in the core facility for next generation sequencing (NXTGNT). His primary focus is on sequencing analysis in the field of pharmacogenomics. 

In one of his recent publications, Laurentijn provides insight into some of the advantages of using IDT’s xGen™ Exome Hyb Panel for pharmacogenetics research studies. Click on the featured content below to learn more about his work and its findings!

Collaborator content

Pan-cancer pharmacogenetics: Targeted sequencing panels or exome sequencing?

In this webinar series, Laurentijn walks us through some of the advantages that IDT’s xGen™ Exome Hyb Panel provides over smaller targeted panel solutions for pan-cancer pharmacogenetics studies.

Learn more

Whole Exome Sequencing Handbook

In this three-part series handbook, we provide an overview of one of Geneseeq’s published studies and the new discoveries that were made from using our xGen™ Exome Hyb Panel.

Learn more